Boots is Committed to Working Collaboratively with Board and New CEO Crown Castle Board Has Presided Over the Misallocation of $22 Billion of Shareholder.
Reminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium Expresses Serious.
Investment firm Shareholder Capital
sent a letter to drugmaker Vanda Pharmaceuticals board
on Thursday asking it to reconsider Future Pak s takeover offer. On April 17, Vanda rejected.
As the Basel rules come under discussion, academics say banks need more shareholder capital because systemic banks still rely too much on debt to support their capital needs.